E L Pritchett
Overview
Explore the profile of E L Pritchett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
114
Citations
1036
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Connolly S, Schnell D, Page R, WILKINSON W, Marcello S, Pritchett E
Am J Cardiol
. 2001 Nov;
88(9):974-9.
PMID: 11703992
We evaluated the efficacy and safety of azimilide, a new class III antiarrhythmic agent that blocks both the slow and fast components of the cardiac-delayed rectifier potassium currents in 4...
2.
Pritchett E, WILKINSON W
J Cardiovasc Electrophysiol
. 2001 Mar;
12(2):131-3.
PMID: 11232607
No abstract available.
3.
Pritchett E, Page R, Connolly S, Marcello S, Schnell D, WILKINSON W
J Am Coll Cardiol
. 2000 Sep;
36(3):794-802.
PMID: 10987602
Objectives: The purpose of this study was to assess the effectiveness of azimilide, a class III antiarrhythmic drug, in reducing the frequency of symptomatic arrhythmia recurrences in patients with atrial...
4.
Al-Khatib S, WILKINSON W, Sanders L, McCarthy E, Pritchett E
Am Heart J
. 2000 Jun;
140(1):142-5.
PMID: 10874276
Background: Quantitative data on the frequency with which transition from intermittent to permanent atrial fibrillation occurs are lacking. We conducted this study to determine the proportion of patients with intermittent...
5.
Pritchett E, WILKINSON W
Am Heart J
. 1999 Oct;
138(5 Pt 1):994-7.
PMID: 10539835
Objectives: This study compared survival between patients taking dofetilide and patients taking placebo in a pooled analysis of randomized clinical trials of patients with supraventricular arrhythmias. Background: Clinical trials of...
6.
Al-Khatib S, Pritchett E
Am Heart J
. 1999 Sep;
138(3 Pt 1):403-13.
PMID: 10467188
Wolff-Parkinson-White syndrome is the most common form of ventricular preexcitation. Understanding this syndrome is fundamental for anyone interested in learning about arrhythmias. This review addresses (1) the historic sequence of...
7.
Pritchett E
Pacing Clin Electrophysiol
. 1998 Jul;
21(7):1457-69.
PMID: 9670191
Between 1962, when the Kefauver-Harris Drug Amendments were passed, and 1996, 20 pharmaceutical compounds were approved and labeled by the FDA as effective antiarrhythmic drugs for some specified cardiac arrhythmia....
8.
Pritchett E
Pacing Clin Electrophysiol
. 1998 May;
21(4 Pt 1):637-40.
PMID: 9584292
No abstract available.
9.
Simons G, Eisenstein E, Shaw L, Mark D, Pritchett E
Am J Cardiol
. 1998 Jan;
80(12):1551-7.
PMID: 9416934
This study assessed the cost effectiveness of inpatient antiarrhythmic therapy initiation for supraventricular tachycardias using a metaanalysis of proarrhythmic risk and a decision analysis that compared inpatient to outpatient therapy...
10.
Riley R, Pritchett E
J Cardiovasc Electrophysiol
. 1997 Jul;
8(7):818-29.
PMID: 9255690
In an era when many electrophysiologic problems are routinely treated with invasive procedures or implantable devices, drugs remain the cornerstones of treatment for atrial fibrillation. Atrial fibrillation may present as...